Mesa Laboratories, Inc.
MLAB
$103.99
$4.204.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 62.14M | 62.84M | 57.83M | 58.17M | 58.90M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 62.14M | 62.84M | 57.83M | 58.17M | 58.90M |
| Cost of Revenue | 23.72M | 23.09M | 21.92M | 20.14M | 21.12M |
| Gross Profit | 38.41M | 39.75M | 35.91M | 38.03M | 37.79M |
| SG&A Expenses | 31.85M | 28.92M | 27.31M | 26.93M | 28.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 60.67M | 57.06M | 53.87M | 51.81M | 54.43M |
| Operating Income | 1.47M | 5.78M | 3.96M | 6.36M | 4.48M |
| Income Before Tax | 461.00K | -2.22M | 3.81M | 3.91M | -275.33M |
| Income Tax Expenses | 7.58M | -541.00K | 384.00K | 517.00K | -20.75M |
| Earnings from Continuing Operations | -7.11M | -1.68M | 3.43M | 3.39M | -254.58M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.11M | -1.68M | 3.43M | 3.39M | -254.58M |
| EBIT | 1.47M | 5.78M | 3.96M | 6.36M | 4.48M |
| EBITDA | 8.97M | 11.28M | 10.03M | 11.82M | 10.77M |
| EPS Basic | -1.31 | -0.31 | 0.63 | 0.63 | -47.20 |
| Normalized Basic EPS | 0.05 | -0.26 | 0.49 | 0.17 | 0.05 |
| EPS Diluted | -1.31 | -0.31 | 0.63 | 0.62 | -47.20 |
| Normalized Diluted EPS | 0.05 | -0.26 | 0.49 | 0.17 | 0.05 |
| Average Basic Shares Outstanding | 5.44M | 5.43M | 5.41M | 5.40M | 5.39M |
| Average Diluted Shares Outstanding | 5.44M | 5.43M | 5.47M | 5.42M | 5.39M |
| Dividend Per Share | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 |
| Payout Ratio | -12.23% | -51.85% | 25.26% | 25.47% | -0.34% |